Pharmacokinetics of an antifibrotic agent, pirfenidone, in haemodialysis patients

被引:26
作者
Taniyama, M
Ohbayashi, S
Narita, M
Nakazawa, R
Hasegawa, S
Azuma, N
Teraoka, S
Ota, K
Yamauchi, S
Margolin, SB
机构
[1] NARITA MEM HOSP, DEPT INTERNAL MED, TOYOHASHI, AICHI 441, JAPAN
[2] TOKATSU CLIN HOSP, DEPT NEPHROL, MATSUDO, CHIBA 271, JAPAN
[3] TOKYO WOMENS MED COLL, DEPT SURG, KIDNEY CTR, SHINJUKU KU, TOKYO 162, JAPAN
[4] KDL INC, CHIYODA KU, TOKYO, JAPAN
[5] MARNAC INC, DALLAS, TX 75225 USA
关键词
pirfenidone; peritoneal sclerosis; haemodialysis;
D O I
10.1007/s002280050252
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:77 / 78
页数:2
相关论文
共 2 条
  • [1] PREVENTIVE EFFECT OF PIRFENIDONE AGAINST EXPERIMENTAL SCLEROSING PERITONITIS IN RATS
    HIDEIKU, S
    TERAOKA, S
    OTA, K
    KOMEMUSHI, S
    FURUTANI, S
    YAMAUCHI, S
    MARGOLIN, SB
    [J]. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1995, 47 (04) : 287 - 291
  • [2] Shimizu F, 1996, J AM SOC NEPHROL, V7, pA2590